» Articles » PMID: 32788072

Baseline Prevalence and Type Distribution of Human Papillomavirus in Sexually Active Non-vaccinated Adolescent Girls from Argentina

Overview
Specialty Microbiology
Date 2020 Aug 14
PMID 32788072
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In 2011, Argentina launched a government-funded national Human papillomavirus (HPV) immunization program incorporating a bivalent HPV vaccine, with a 0-1-6-month schedule, for girls 11 years of age, born after January 2000. Monitoring the changes of HPV infection prevalence among young women has been proposed as an endpoint for early assessment of HPV vaccination programs. However, the data on HPV prevalence at young ages are very limited. The aim of this work was to determine the prevalence of HPV infection and type-specific distribution in sexually active 15-17-year-old non-vaccinated girls. Cervical samples from 1073 adolescents were collected for HPV detection and genotyping using the BSGP5+/GP6+PCR-reverse line blot (RLB) assay. Out of 957 specimens analyzed, 56.3% were positive for any HPV type; 42.2% harbored at least one high-risk HPV (HR-HPV) type and 30.8% low-risk HPV (LR-HPV) types. Multiple and single infections were identified in 36.3% and 20.0% of the samples respectively. The 6 most common HR-HPV types were HPV16 (11.1%), HPV52 (10.8%), HPV56 (8.3%), HPV51 (7.4%), HPV58 (7.3%) and HPV31 (7.1%). The prevalence of HR-HPV-16/18 was 15.2%. In conclusion, results confirm that HPV (particularly HR-types) are very common among sexually active adolescents, and prevalence rises quickly after their sexual debut. Our HPV type-specific prevalence baseline may be used to monitor post-vaccinal longitudinal changes in Argentina.

Citing Articles

HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.

Hernandez-Silva C, Ramirez de Arellano A, Pereira-Suarez A, Ramirez-Lopez I Viruses. 2024; 16(3).

PMID: 38543693 PMC: 10974876. DOI: 10.3390/v16030327.


Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women.

Bobadilla M, Villagra V, Castro H, von Horoch M, Araya S, Deluca G Pathogens. 2024; 13(3).

PMID: 38535552 PMC: 10974315. DOI: 10.3390/pathogens13030209.


High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay.

Bobadilla M, Villagra V, Ortiz V, Deluca G, de Paula V PLoS One. 2023; 18(4):e0283542.

PMID: 37023094 PMC: 10079089. DOI: 10.1371/journal.pone.0283542.


Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening.

Chrysostomou A, Kostrikis L Life (Basel). 2020; 10(11).

PMID: 33227939 PMC: 7699148. DOI: 10.3390/life10110290.


Strong reduction in prevalence of HPV16/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina.

Gonzalez J, Deluca G, Correa R, Liotta D, Basiletti J, Fellner M Papillomavirus Res. 2020; 10:100208.

PMID: 33161174 PMC: 7683272. DOI: 10.1016/j.pvr.2020.100208.